Role of PI3K/Akt signaling in insulin-like growth factor-1 (IGF-1) skin tumor promotion

被引:60
|
作者
Wilker, E [1 ]
Lu, J [1 ]
Rho, O [1 ]
Carbajal, S [1 ]
Beltrán, L [1 ]
DiGiovanni, J [1 ]
机构
[1] Univ Texas, MD Anderson Canc Ctr, Div Sci Pk Res, Dept Carcinogenesis, Smithville, TX 78957 USA
关键词
PI3K; Akt; tumor promotion; cell cycle;
D O I
10.1002/mc.20132
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Overexpression of human IGF-1 with the bovine keratin 5 (BK5) promoter (BK5.IGF-1 transgenic mice) induces persistent epidermal hyperplasia and leads to spontaneous skin tumor formation. In previous work, PI3K and Akt activities were found to be elevated in the epidermis of BK5.IGF-1 transgenic mice compared to nontransgenic littermates. In the present study, we examined the importance of the PI3K/Akt signaling pathway in mediating the skin phenotype and the skin tumor promoting action of IGF-1 in these mice. Western blot analyses with epidermal lysates showed that signaling components downstream of PI3K/Akt were altered in epidermis of BK5.IGF-1 mice. Increased phosphorylation of GSK-3 (Ser(9/21)), TSC2(Thr(1462)), and mTOR(Ser(2448)) was observed. In addition, hypophosphorylation and increased protein levels of P-catenin were observed in the epidermis of BK5.IGF-1 mice. These data suggested that components downstream of Akt might be affected, including cell cycle machinery in the epidermis of BK5.IGF-1 mice. Protein levels of cyclins (D1, E, A), E2F1, and E2F4 were all elevated in the epidermis of BK5.IGF-1 mice. Also, immunoprecipitation experiments demonstrated an increase in cdk4/cyclin D1 and cdk2/cyclin E complex formation, suggesting increased cdk activity in the epidermis of transgenic mice. In further studies, the PI3K inhibitor, LY294002, significantly blocked IGF-1-mediated epidermal proliferation and skin tumor promotion in DMBA-initiated BK5.IGF-1 mice. In addition, inhibition of PI3K/Akt with LY294002 reversed many of the cell cycle related changes observed in untreated transgenic animals. Collectively, the current results supported the hypothesis that elevated PI3K/Akt activity and subsequent activation of one or more downstream effector pathways contributed significantly to the tumor promoting action of IGF-1 in the epidermis of BK5.IGF-1 mice. (c) 2005 Wiley-Liss, Inc.
引用
收藏
页码:137 / 145
页数:9
相关论文
共 50 条
  • [31] Role of insulin-like growth factor-1 (IGF-1) in obliterative bronchiolitis after lung transplantation.
    Charpin, JM
    Stern, M
    Grenet, D
    Epardeau, B
    Israël-Biet, D
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A276 - A276
  • [32] Insulin-Like Growth Factor-1 (IGF-1) and Its Monitoring in Medical Diagnostic and in Sports
    Bailes, Julian
    Soloviev, Mikhail
    BIOMOLECULES, 2021, 11 (02) : 1 - 15
  • [33] Effect of insulin-like growth factor-1 (IGF-1) on muscle and bone growth in experimental models
    Tirapegui, J
    INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION, 1999, 50 (04) : 231 - 236
  • [34] Pattern of Retinopathy of Prematurity and its Correlation with Insulin-like Growth Factor-1 (IGF-1)
    Kant, Shri
    Professor Usha
    Professor Bhatia
    Anthony, Kamson
    Seth, Gaurav
    ANNALS OF OPHTHALMOLOGY, 2009, 41 (3-4) : 157 - 161
  • [35] Effects of insulin-like growth factor-1 (IGF-1) and amifostine in spinal cord reirradiation
    Nieder, C
    Price, RE
    Rivera, B
    Andratschke, N
    Ang, KK
    STRAHLENTHERAPIE UND ONKOLOGIE, 2005, 181 (11) : 691 - 695
  • [36] Suckling induced insulin-like growth factor-1 (IGF-1) release in mother rats
    Leko, Andras H.
    Cservenak, Melinda
    Dobolyi, Arpad
    GROWTH HORMONE & IGF RESEARCH, 2017, 37 : 7 - 12
  • [37] Recombinant insulin-like growth factor-1 as a therapy for IGF-1 deficiency in renal failure
    Ross G. Clark
    Pediatric Nephrology, 2005, 20 : 290 - 294
  • [38] Recombinant insulin-like growth factor-1 as a therapy for IGF-1 deficiency in renal failure
    Clark, RG
    PEDIATRIC NEPHROLOGY, 2005, 20 (03) : 290 - 294
  • [39] SERUM INSULIN-LIKE GROWTH FACTOR-1 (IGF-1) AND ACUTE BRAIN DYSFUNCTION IN THE ICU
    Girard, Timothy
    Morandi, Alessandro
    Gunther, Max
    Pandharipande, Pratik
    Jackson, James
    Thompson, Jennifer
    Shintani, Ayumi
    Ely, E.
    CRITICAL CARE MEDICINE, 2009, 37 (12) : A355 - A355
  • [40] The role of the insulin-like growth factor 1 (IGF-1) in skeletal muscle physiology
    Philippou, Anastassios
    Maridaki, Maria
    Halapas, Antonis
    Koutsilieris, Michael
    IN VIVO, 2007, 21 (01): : 45 - 54